Dabur Pharma inks agreement with Thai firm

New Delhi, Apr 9 (UNI) Dabur Pharma today said it has signed an agreement with Thailand-based Government Pharmaceutical Organization (GPO) for generic version of one of its key anti-cancer products.

''Dabur Pharma is committed to providing high quality anti-cancer products at cost effective prices. The agreement with GPO has been signed for generic Docetaxel Injection at a very special price,'' Dabur Pharma CEO Ajay Kumar Vij said in a statement.

GPO will be importing the product in Thailand and then making it available to needy patients, he added.

UNI SBA SG GC1726